Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001701634 | SCV000236382 | likely benign | not provided | 2021-06-22 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28144010, 27488758, 30564623) |
Eurofins Ntd Llc |
RCV000183899 | SCV000338346 | benign | not specified | 2016-01-22 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000331989 | SCV000455467 | likely benign | Limb-girdle muscular dystrophy, recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000389000 | SCV000455468 | likely benign | Qualitative or quantitative defects of delta-sarcoglycan | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Labcorp Genetics |
RCV000639556 | SCV000761132 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2F | 2025-01-30 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170139 | SCV001332680 | benign | Cardiomyopathy | 2018-03-09 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000183899 | SCV002041538 | likely benign | not specified | 2021-11-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001701634 | SCV002050186 | likely benign | not provided | 2020-10-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000639556 | SCV003931760 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2F | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233487 | SCV003931761 | likely benign | Dilated cardiomyopathy 1L | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001701634 | SCV005220287 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001701634 | SCV001930302 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001701634 | SCV001965770 | likely benign | not provided | no assertion criteria provided | clinical testing |